In May 2018, Ovarian Cancer Australia brought together leading Australian and international researchers, clinicians and industry representatives for a one day independent ovarian cancer symposium for health professionals.

Symposium program

Professor Ursula Matulonis

Presenting on PARP inhibitors: opportunities, challenges and new directions
Watch now

Professor Clare Scott

Presenting on the role of PARP inhibitors in non-BRCA ovarian cancer
Watch now

Professor John Zalcberg

Presenting on: the Ovarian Cancer Clinical Quality Registry, its progress and challenges.
Watch now

Dr George Au-Yeung

Presenting on immunotherapy combinations in high-grade serous ovarian cancer
Watch now

Dr Tarek Meniawy

Presenting on immunotherapy for ovarian cancer
Watch now

Dr Dale Garsed

Presenting on 'Surviving ovarian cancer: the role of the immune response'
Watch now

Dr Olga Kondrashova

Presenting on resistance and sensitivity to PARP inhibition in ovarian cancer
Watch now

Dr Peter Savas

Presenting on 'Perspectives from breast cancer – immunotherapy and precision oncology'
Watch now

This event was supported by Astra Zeneca in alliance with the Australia New Zealand Gynaecological Oncology Group (ANZGOG)